UBEOF(UBEOF)
UBEOF
No analyst ratings available
No analyst price targets available for UBEOF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E | FY2030E | FY2031E |
|---|---|---|---|---|---|
| Revenue Avg | $491.45B | $492.85B | $467.00B | $472.09B | $498.52B |
| Low | $478.87B | $490.65B | $459.94B | $464.96B | $490.99B |
| High | $504.48B | $493.94B | $473.75B | $478.91B | $505.72B |
| EBITDA Avg | $65.98B | $74.32B | $80.74B | $82.51B | $87.57B |
| Low | $65.33B | $73.56B | $79.90B | $81.66B | $86.65B |
| High | $66.59B | $75.04B | $81.56B | $83.33B | $88.45B |
| EBIT Avg | $34.95B | $40.56B | $45.26B | $45.56B | $48.96B |
| Low | $34.31B | $39.80B | $44.41B | $44.71B | $48.04B |
| High | $35.57B | $41.28B | $46.07B | $46.38B | $49.84B |
| Net Income Avg | $24.39B | $28.55B | $32.05B | $32.27B | $34.80B |
| Low | $23.92B | $27.99B | $31.42B | $31.63B | $34.11B |
| High | $24.85B | $29.09B | $32.65B | $32.87B | $35.45B |
| EPS Avg | $251.11 | $293.93 | $329.88 | $332.16 | $358.16 |
| Low | $246.18 | $288.16 | $323.40 | $325.64 | $351.13 |
| High | $255.83 | $299.45 | $336.08 | $338.40 | $364.89 |
| Analysts (Rev / EPS) | 3 / 1 | 3 / 1 | 1 / 1 | 2 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|
| Revenue Avg | $121.04B | $126.04B | $128.67B |
| Low | $118.81B | $124.52B | $126.72B |
| High | $123.27B | $127.56B | $130.63B |
| EBITDA Avg | — | — | — |
| Low | — | — | — |
| High | — | — | — |
| EBIT Avg | — | — | — |
| Low | — | — | — |
| High | — | — | — |
| Net Income Avg | — | — | — |
| Low | — | — | — |
| High | — | — | — |
| EPS Avg | — | — | — |
| Low | — | — | — |
| High | — | — | — |
| Analysts (Rev / EPS) | 2 / — | 2 / — | 1 / — |